User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 17 results.
    • Journal article
    Intérêt des hautes doses de cytosine-arabinoside dans le traitement des leucémies aiguës résistantes.
    Witz, F. Olive, D. Lederlin, P. Bordigoni, P. Troussard, X.[UCL] Grosbois, B. Schaison, G. Cornu, Guy[UCL] (1987) Presse médicale (Paris, France : 1983) — Vol. 16, no. 4, p. 159-62 (1987)
    • Speech
    Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study.
    Delarue, R. Mounier, N. Haioun, C. Coiffier, B. Gisselbrecht, C. Ghesquieres, H. Lederlin, P. Blanc, M. Recher, C. Hermine, O. Reyes, F. Tilly, H. Bosly, André[UCL] (2006) 48th Annual Meeting of the American-Society-of-Hematology — Orlando(Fl)
    • Journal article
    Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: The LNH87-1 study
    Tilly, H. Mounier, N. Lederlin, P. Briere, J Dupriez, B. Sebban, C. Bosly, André[UCL] Biron, P. Nouvel, C. Herbrecht, R. Bordessoule, D. Coiffier, B. (2000) Journal of Clinical Oncology — Vol. 18, no. 6, p. 1309-1315 (2000)
    • Journal article
    Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Mounier, N. Briere, J Gisselbrecht, C. Emile, JF Lederlin, P. Sebban, C. Berger, F. Bosly, André[UCL] Morel, Priscilla[UCL] Tilly, H. Bouabdallah, R. Reyes, F. Gaulard, P. Coiffier, B. (2003) Blood — Vol. 101, no. 11, p. 4279-4284 (2003)
    • Journal article
    Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study
    Haioun, C. Lepage, E. Gisselbrecht, C. Salles, G. Coiffier, B. Brice, P. Bosly, André[UCL] Morel, Priscilla[UCL] Nouvel, C. Tilly, H. Lederlin, P. Sebban, C. Briere, J Gaulard, P. Reyes, F. (2000) Journal of Clinical Oncology — Vol. 18, no. 16, p. 3025-3030 (2000)
    • Journal article
    [High-dose Cytosine-arabinoside for the Treatment of Resistant Acute-leukemia]
    Witz, F. Olive, D. Lederlin, P. Bordigoni, P. Troussard, X. Grosbois, B. Schaison, G. Cornu, Guy[UCL] (1987) La Presse Medicale — Vol. 16, no. 4, p. 159-162 (1987)
    • Journal article
    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
    • Journal article
    A multivariate analysis of the survival of patients with aggressive lymphoma - Variations in the predictive value of prognostic factors during the course of the disease
    Mounier, N. Morel, Priscilla[UCL] Haioun, C. Coiffier, B. Tilly, H. Chatelain, Christian Lederlin, P. Thyss, A Herbrecht, R. Gisselbrecht, C. Lepage, E. (1998) Cancer — Vol. 82, no. 10, p. 1952-1962 (1998)
    • Speech
    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.
    Bosly, André[UCL] Ferrant, Augustin[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1998) —
    • Speech
    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.
    Bosly, André[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1997) —
    • Speech
    Late intensification is superior to early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma. A randomized study from the GELA: LNH RP93.
    Bosly, André[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Coiffier, B. (1997) —
    • Speech
    High efficacy of recombinant urate oxidase in prevention of renal failure related to tumor lysis syndrome (TLS).
    Lascombes, F Sommelet, D Gebhard, F Leverger, G. Schaison, R Pinkerton, R. Bosly, André[UCL] Patte, C. Boos, J Smedmyr, B Lederlin, P. Stryckmans, P. (1998) —
    • Speech
    90yttrium Ibritumomab Tiuxetan (zevalin) Combined With Beam (z-beam) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed Or Refractory Follicular Lymphoma. a Gela Phase Ii Prospective Study
    Gisselbrecht, C. Decaudin, D. Mounier, N. Tilly, H. Ribrag, V. Sebban, C. Milpied, N. Morschhauser, F. Coiffier, B. Le Gouill, S. Lederlin, P. Delarue, R. Laurent, Gabrielle[UCL] Bosly, André[UCL] (2009) 14th Annual Meeting of the European-Hematology-Association — Berlin(Germany)
    • Speech
    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93
    Bosly, André[UCL] Ferrant, Augustin[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1998) —
    • Journal article
    Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients
    Haioun, C. Besson, C Lepage, E. Thieblemont, C Simon, D Rose, C Tilly, H. Sonet, Anne Lederlin, P. Attal, M. Briere, J Reyes, F. (2000) Annals of Oncology — Vol. 11, no. 6, p. 685-690 (2000)
    • Journal article
    Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2
    Haioun, C. Lepage, E. Gisselbrecht, C. Bastion, Y. Coiffier, B. Brice, P. Bosly, André[UCL] Dupriez, B. Nouvel, C. Tilly, H. Lederlin, P. Biron, P. Briere, J Gaulard, P. Reyes, F. (1997) Journal of Clinical Oncology — Vol. 15, no. 3, p. 1131-1137 (1997)
    • Journal article
    Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'etudes des Lymphomes de l'Adulte H89 trial
    Ferme, C Ferrant, Augustin[UCL] Sebban, C. Hennequin, C Divine, M. Lederlin, P. Gabarre, J Caillot, D. Bordessoule, D. Brice, P. Moullet, I Berger, F. Lepage, E. (2000) Blood — Vol. 95, no. 7, p. 2246-2252 (2000)